Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837798 · ClinicalTrials.gov registry record
RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 5,379
- Enrollment target
NCT00837798: Completed study, sponsored by Abbott Medical Devices.
NCT00837798 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 5,379 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00837798 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 5,379 participants
- Enrollment target
Study Summary
The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.
Interventions
- DEVICE CRM Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,379 participants |
| Start Date | 2006-10 |
| Est. Completion | 2012-04 |
What the finished NCT00837798 record still lists
NCT00837798 is an observational study that tracks outcomes without assigning an intervention. Its 5,379 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which CRM Device is the first listed.
NCT00837798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00837798 about?
NCT00837798 is a clinical study titled "RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population". The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.
What is the current status of trial NCT00837798?
This trial is currently completed. The enrollment target is 5,379 participants. The study started on 2006-10. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00837798?
The interventions under investigation include: CRM Device (DEVICE).
Who is sponsoring clinical trial NCT00837798?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia